Clinical Trial Update: Prolonged Clinical Follow-up of OPTIMA-5 [Phase 4]

View source ↗

Summary

This update reports prolonged clinical follow-up from the OPTIMA-5 Phase 4 trial conducted in patients with ST-segment elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: ST-segment Elevation Myocardial Infarction (STEMI) | Phase 4 | Status: COMPLETED